Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 2Phase 1/2 2Phase 1 2Phase 2/3 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 7Ovarian Neoplasms 5Liposarcoma 2Leiomyosarcoma 2Peritoneal Neoplasms 1Fallopian Tube Neoplasms 1

Interventions

Doxorubicin 8Ifosfamide 6Radiotherapy 4Dacarbazine 3Trabectedin 2Filgrastim 2pegfilgrastim 1olaratumab 1indolepropanol phosphate 1anlotinib 1Watchful Waiting 1Tablets 1Surgical Procedures, Operative 1Rosuvastatin Calcium 1Radiotherapy, Conformal 1PM 01183 1Observation 1Neoadjuvant Therapy 1Midazolam 1Etoposide 1Digoxin 1Diathermy 1Combined Modality Therapy 1Chemotherapy, Adjuvant 1ADI PEG20 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Leiomyosarcoma × Trabectedin × Clear all
NCT01692678 2018-07-11

A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma

Xian-Janssen Pharmaceutical Ltd.

Phase 3 Completed
16 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma

NCT01343277 2016-08-26

A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma

Janssen Research & Development, LLC

Phase 3 Completed
579 enrolled 13 charts
Sarcoma

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡